SLC5A6 Polyclonal antibody

SLC5A6 Polyclonal Antibody for WB, IP, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, IP, ELISA

Conjugate

Unconjugated

Cat no : 26407-1-AP

Synonyms

SLC5A6, SMVT



Tested Applications

Positive WB detected inCaco-2 cells, mouse brain tissue, mouse small intestine tissue, COLO 320 cells, rat brain tissue
Positive IP detected inmouse brain tissue

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:1000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Published Applications

WBSee 2 publications below

Product Information

The immunogen of 26407-1-AP is SLC5A6 Fusion Protein expressed in E. coli.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman, mouse
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen SLC5A6 fusion protein Ag23907
Full Name solute carrier family 5 (sodium-dependent vitamin transporter), member 6
Observed Molecular Weight 69 kDa
GenBank Accession NumberBC012806
Gene Symbol SLC5A6
Gene ID (NCBI) 8884
RRIDAB_2880502
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Protocols

Product Specific Protocols
WB protocol for SLC5A6 antibody 26407-1-APDownload protocol
IP protocol for SLC5A6 antibody 26407-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
human,mouseWB

Nat Metab

Vitamin B5 supports MYC oncogenic metabolism and tumor progression in breast cancer

Authors - Peter Kreuzaler
humanWB

Mol Cell Proteomics

Hypoxia is a dominant remodeler of the effector T cell surface proteome relative to activation and regulatory T cell suppression.

Authors - James R Byrnes